StonvexLoading…
StonvexStonvexStonvexCore line items from CSIQ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.60B | $5.99B | $7.61B | $7.47B |
Operating Income | $43.16M | $-30.08M | $453.32M | $356.06M |
Net Income | $-104.13M | $36.05M | $274.19M | $298.56M |
EPS (Diluted) | $-2.50 | $0.54 | $3.87 | $3.44 |
Total Assets | $15.17B | $13.51B | $11.90B | $9.04B |
Total Liabilities | $10.90B | $9.36B | $8.19B | $6.73B |
Cash & Equivalents | $1.37B | $1.70B | $1.94B | $981.43M |
Free Cash Flow OCF − CapEx | $-1.21B | $-2.00B | $-431.85M | $289.52M |
Shares Outstanding | 67.81M | 66.95M | 66.16M | 64.51M |